• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追踪细胞外囊泡中的基质细胞蛋白 SPARC 作为一种非破坏性方法来评估基于脂质的抗纤维化治疗。

Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments.

机构信息

Institute of Pharmacy, Friedrich Schiller University of Jena, Jena, Germany.

Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.

出版信息

Commun Biol. 2022 Oct 30;5(1):1155. doi: 10.1038/s42003-022-04123-z.

DOI:10.1038/s42003-022-04123-z
PMID:36310239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9618575/
Abstract

Uncovering the complex cellular mechanisms underlying hepatic fibrogenesis could expedite the development of effective treatments and noninvasive diagnosis for liver fibrosis. The biochemical complexity of extracellular vesicles (EVs) and their role in intercellular communication make them an attractive tool to look for biomarkers as potential alternative to liver biopsies. We developed a solid set of methods to isolate and characterize EVs from differently treated human hepatic stellate cell (HSC) line LX-2, and we investigated their biological effect onto naïve LX-2, proving that EVs do play an active role in fibrogenesis. We mined our proteomic data for EV-associated proteins whose expression correlated with HSC treatment, choosing the matricellular protein SPARC as proof-of-concept for the feasibility of fluorescence nanoparticle-tracking analysis to determine an EV-based HSCs' fibrogenic phenotype. We thus used EVs to directly evaluate the efficacy of treatment with S80, a polyenylphosphatidylcholines-rich lipid, finding that S80 reduces the relative presence of SPARC-positive EVs. Here we correlated the cellular response to lipid-based antifibrotic treatment to the relative presence of a candidate protein marker associated with the released EVs. Along with providing insights into polyenylphosphatidylcholines treatments, our findings pave the way for precise and less invasive diagnostic analyses of hepatic fibrogenesis.

摘要

揭示肝纤维化的复杂细胞机制可以加速有效的治疗方法和非侵入性诊断肝纤维化的发展。细胞外囊泡(EVs)的生化复杂性及其在细胞间通讯中的作用使它们成为寻找生物标志物的有吸引力的工具,作为肝活检的潜在替代方法。我们开发了一套从不同处理的人肝星状细胞(HSC)系 LX-2 中分离和表征 EVs 的方法,并研究了它们对幼稚 LX-2 的生物学效应,证明 EVs 在纤维化中确实发挥了积极作用。我们对 EV 相关蛋白的蛋白质组学数据进行了挖掘,这些蛋白的表达与 HSC 治疗相关,选择细胞外基质蛋白 SPARC 作为荧光纳米颗粒跟踪分析确定基于 EV 的 HSCs 纤维化表型的可行性的概念验证。因此,我们使用 EVs 直接评估富含多烯磷脂酰胆碱的 S80 治疗的疗效,发现 S80 降低了 SPARC 阳性 EVs 的相对存在。在这里,我们将细胞对基于脂质的抗纤维化治疗的反应与与释放的 EV 相关的候选蛋白标记物的相对存在相关联。我们的研究结果不仅为多烯磷脂酰胆碱治疗提供了新的见解,还为肝纤维化的精确和非侵入性诊断分析铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/729f7e9f835d/42003_2022_4123_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/da870095582f/42003_2022_4123_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/acc6674dc0ba/42003_2022_4123_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/c356b3f05b0e/42003_2022_4123_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/e62361d89939/42003_2022_4123_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/b8c7df594a8f/42003_2022_4123_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/729f7e9f835d/42003_2022_4123_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/da870095582f/42003_2022_4123_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/acc6674dc0ba/42003_2022_4123_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/c356b3f05b0e/42003_2022_4123_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/e62361d89939/42003_2022_4123_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/b8c7df594a8f/42003_2022_4123_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ac/9618575/729f7e9f835d/42003_2022_4123_Fig6_HTML.jpg

相似文献

1
Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments.追踪细胞外囊泡中的基质细胞蛋白 SPARC 作为一种非破坏性方法来评估基于脂质的抗纤维化治疗。
Commun Biol. 2022 Oct 30;5(1):1155. doi: 10.1038/s42003-022-04123-z.
2
Formulating elafibranor and obeticholic acid with phospholipids decreases drug-induced association of SPARC to extracellular vesicles from LX-2 human hepatic stellate cells.将依拉非尼和奥贝胆酸与磷脂一起配制可减少药物诱导的SPARC与LX-2人肝星状细胞的细胞外囊泡的结合。
Eur J Pharm Biopharm. 2023 Jan;182:32-40. doi: 10.1016/j.ejpb.2022.11.025. Epub 2022 Dec 2.
3
Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation.细胞激活过程中肝星状细胞外囊泡功能和蛋白质组组成的动态变化。
Cells. 2020 Jan 25;9(2):290. doi: 10.3390/cells9020290.
4
Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.肝星状细胞自噬抑制细胞外囊泡释放以减轻肝纤维化。
J Hepatol. 2020 Nov;73(5):1144-1154. doi: 10.1016/j.jhep.2020.04.044. Epub 2020 May 8.
5
Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.人诱导多能干细胞衍生的细胞外囊泡可减少肝星状细胞的激活和肝纤维化。
JCI Insight. 2019 Jun 11;5(14):125652. doi: 10.1172/jci.insight.125652.
6
Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice.色谱可扩展方法分离间充质干细胞来源的工程细胞外囊泡,用于治疗小鼠肝纤维化。
Int J Mol Sci. 2023 May 31;24(11):9586. doi: 10.3390/ijms24119586.
7
Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.血清细胞外囊泡含有 SPARC 和 LRG1,可作为结直肠癌的生物标志物,且其存在位置与肿瘤原发部位有关。
EBioMedicine. 2019 Dec;50:211-223. doi: 10.1016/j.ebiom.2019.11.003. Epub 2019 Nov 18.
8
Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.肝星状细胞衍生的血小板衍生生长因子受体-α富集的细胞外囊泡通过 SHP2 促进小鼠肝纤维化。
Hepatology. 2018 Jul;68(1):333-348. doi: 10.1002/hep.29803. Epub 2018 May 10.
9
Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.全面表征肝细胞衍生的细胞外囊泡,鉴定其对酒精性肝炎小鼠肝星状细胞的直接 miRNA 调控和基于 DAMPs 的肝巨噬细胞 IL-1β和 IL-17 的上调作用。
J Mol Med (Berl). 2020 Jul;98(7):1021-1034. doi: 10.1007/s00109-020-01926-7. Epub 2020 Jun 18.
10
Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.脂变肝细胞来源的细胞外囊泡在化学缺氧下促进肝星状细胞的促纤维化表型。
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165857. doi: 10.1016/j.bbadis.2020.165857. Epub 2020 Jun 5.

引用本文的文献

1
Extracellular vesicles: key mediators in embryo production.细胞外囊泡:胚胎生产中的关键介质
Front Vet Sci. 2025 Aug 20;12:1641966. doi: 10.3389/fvets.2025.1641966. eCollection 2025.
2
Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease.细胞衍生的纳米囊泡的形成与研究——作为治疗慢性肝病的潜在疗法。
Adv Healthc Mater. 2023 Dec;12(30):e2300811. doi: 10.1002/adhm.202300811. Epub 2023 Sep 17.

本文引用的文献

1
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.PRIDE 数据库资源在 2022 年:一个基于质谱的蛋白质组学证据的中心。
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552. doi: 10.1093/nar/gkab1038.
2
SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism.抑制 SPARC 可通过扰乱肝脏脂质代谢加速非酒精性脂肪性肝病相关肝细胞癌的发展。
Liver Int. 2021 Jul;41(7):1677-1693. doi: 10.1111/liv.14857. Epub 2021 Mar 11.
3
Separation and zeta-potential determination of proteins and their oligomers using electrical asymmetrical flow field-flow fractionation (EAF4).
使用电气不对称流场流分离(EAF4)分离和测定蛋白质及其低聚物的zeta 电位。
J Chromatogr A. 2020 Dec 6;1633:461625. doi: 10.1016/j.chroma.2020.461625. Epub 2020 Oct 14.
4
Separation and characterization of extracellular vesicles from human plasma by asymmetrical flow field-flow fractionation.采用不对称流场流分离技术从人血浆中分离和表征细胞外囊泡。
Anal Chim Acta. 2020 Aug 29;1127:234-245. doi: 10.1016/j.aca.2020.06.071. Epub 2020 Jul 11.
5
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.细胞外囊泡和颗粒生物标志物可定义多种人类癌症。
Cell. 2020 Aug 20;182(4):1044-1061.e18. doi: 10.1016/j.cell.2020.07.009. Epub 2020 Aug 13.
6
Systematic Evaluation of PKH Labelling on Extracellular Vesicle Size by Nanoparticle Tracking Analysis.通过纳米颗粒跟踪分析对细胞外囊泡大小进行 PKH 标记的系统评价。
Sci Rep. 2020 Jun 12;10(1):9533. doi: 10.1038/s41598-020-66434-7.
7
MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments.MIFlowCyt-EV:细胞外囊泡流式细胞术实验标准化报告框架
J Extracell Vesicles. 2020 Feb 3;9(1):1713526. doi: 10.1080/20013078.2020.1713526. eCollection 2020.
8
Liver-derived extracellular vesicles: A cell by cell overview to isolation and characterization practices.肝源性细胞外囊泡:从细胞到分离和表征实践的概述。
Biochim Biophys Acta Gen Subj. 2021 Apr;1865(4):129559. doi: 10.1016/j.bbagen.2020.129559. Epub 2020 Feb 19.
9
Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells.磷脂-药物制剂的协同作用显著使促纤维化的人肝星状细胞失活。
Pharmaceutics. 2019 Dec 12;11(12):676. doi: 10.3390/pharmaceutics11120676.
10
Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways.白蛋白自修饰脂质体通过 SPARC 依赖性途径治疗肝纤维化。
Int J Pharm. 2020 Jan 25;574:118940. doi: 10.1016/j.ijpharm.2019.118940. Epub 2019 Dec 9.